Acorda Therapeutics News (NASDAQ:ACOR)

Latest Acorda Therapeutics News Headlines
DateTimeSource
Headline
02/22/20075:09PMPRNUSThird Point Calls for Board to Sell Acorda Therapeutics, Inc.
NEW YORK, Feb. 22 /PRNewswire/ -- Third Point LLC today announced that it has filed a Schedule 13D with the Securities and Exchange Commission calling upon the Board of Directors of Acorda Therapeutics, Inc. (NASDAQ:ACOR) to initiate a process to sell the Company in its entirety, and that the following letter has been... More...>>


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
33 site:2us nasdaq acor080517 12:45 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )